Cargando…

DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4

BACKGROUND: Chinese herbal formulae are composed of complex components and produce comprehensive pharmacological effects. Unlike chemical drugs that have only one clear single target, the components of Chinese herbal formulae have multiple channels and targets. How to discover the pharmacological ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yong, Li, Chun, Liu, Zhongyang, Shi, Tianjiao, Wang, Qiyan, Li, Dong, Wu, Yan, Han, Jing, Guo, Shuzhen, Tang, Binghua, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933388/
https://www.ncbi.nlm.nih.gov/pubmed/24555740
http://dx.doi.org/10.1186/1472-6882-14-67
_version_ 1782304925810688000
author Wang, Yong
Li, Chun
Liu, Zhongyang
Shi, Tianjiao
Wang, Qiyan
Li, Dong
Wu, Yan
Han, Jing
Guo, Shuzhen
Tang, Binghua
Wang, Wei
author_facet Wang, Yong
Li, Chun
Liu, Zhongyang
Shi, Tianjiao
Wang, Qiyan
Li, Dong
Wu, Yan
Han, Jing
Guo, Shuzhen
Tang, Binghua
Wang, Wei
author_sort Wang, Yong
collection PubMed
description BACKGROUND: Chinese herbal formulae are composed of complex components and produce comprehensive pharmacological effects. Unlike chemical drugs that have only one clear single target, the components of Chinese herbal formulae have multiple channels and targets. How to discover the pharmacological targets of Chinese herbal formulae and their underlying molecular mechanism are still under investigation. METHODS: DanQi pill (DQP), which is one of the widely prescribed traditional Chinese medicines, is applied as an example drug. In this study, we used the drug target prediction model (DrugCIPHER-CS) to examine the underlying molecular mechanism of DQP, followed by experimental validation. RESULTS: A novel therapeutic effect pattern of DQP was identified. After determining the compounds in DQP, we used DrugCIPHER-CS to predict their potential targets. These potential targets were significantly enriched in well-known cardiovascular disease-related pathways. For example, the biological processes of neuroactive ligand–receptor interaction, calcium-signaling pathway, and aminoacyl–tRNA biosynthesis were involved. A new and significant pathway, arachidonic acid (AA) metabolism, was also identified in this study. This predicted pathway alteration was validated with an animal model of heart failure (HF). Results show that DQP had effect both on thromboxane B2 (TXB2) and Prostaglandin I2 (PGI2) in different patterns. It can down-regulate the TXB2 and up-regulate the PGI2 in diverse way. Remarkably, it also had effect on cyclooxygenase (COX)-1 and COX2 by suppressing their levels, which may be the critical and novel mechanism of cardiacprotective efficacy for DQP. Furthermore, leukotrienes B4 (LTB4) receptor, another key molecule of AA metabolism which finally mediated gastrotoxic leukotrienes, was also reduced by DQP. CONCLUSIONS: The combination of drug target prediction and experimental validation provides new insights into the complicated mechanism of DQP.
format Online
Article
Text
id pubmed-3933388
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39333882014-02-25 DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4 Wang, Yong Li, Chun Liu, Zhongyang Shi, Tianjiao Wang, Qiyan Li, Dong Wu, Yan Han, Jing Guo, Shuzhen Tang, Binghua Wang, Wei BMC Complement Altern Med Research Article BACKGROUND: Chinese herbal formulae are composed of complex components and produce comprehensive pharmacological effects. Unlike chemical drugs that have only one clear single target, the components of Chinese herbal formulae have multiple channels and targets. How to discover the pharmacological targets of Chinese herbal formulae and their underlying molecular mechanism are still under investigation. METHODS: DanQi pill (DQP), which is one of the widely prescribed traditional Chinese medicines, is applied as an example drug. In this study, we used the drug target prediction model (DrugCIPHER-CS) to examine the underlying molecular mechanism of DQP, followed by experimental validation. RESULTS: A novel therapeutic effect pattern of DQP was identified. After determining the compounds in DQP, we used DrugCIPHER-CS to predict their potential targets. These potential targets were significantly enriched in well-known cardiovascular disease-related pathways. For example, the biological processes of neuroactive ligand–receptor interaction, calcium-signaling pathway, and aminoacyl–tRNA biosynthesis were involved. A new and significant pathway, arachidonic acid (AA) metabolism, was also identified in this study. This predicted pathway alteration was validated with an animal model of heart failure (HF). Results show that DQP had effect both on thromboxane B2 (TXB2) and Prostaglandin I2 (PGI2) in different patterns. It can down-regulate the TXB2 and up-regulate the PGI2 in diverse way. Remarkably, it also had effect on cyclooxygenase (COX)-1 and COX2 by suppressing their levels, which may be the critical and novel mechanism of cardiacprotective efficacy for DQP. Furthermore, leukotrienes B4 (LTB4) receptor, another key molecule of AA metabolism which finally mediated gastrotoxic leukotrienes, was also reduced by DQP. CONCLUSIONS: The combination of drug target prediction and experimental validation provides new insights into the complicated mechanism of DQP. BioMed Central 2014-02-20 /pmc/articles/PMC3933388/ /pubmed/24555740 http://dx.doi.org/10.1186/1472-6882-14-67 Text en Copyright © 2014 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Wang, Yong
Li, Chun
Liu, Zhongyang
Shi, Tianjiao
Wang, Qiyan
Li, Dong
Wu, Yan
Han, Jing
Guo, Shuzhen
Tang, Binghua
Wang, Wei
DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
title DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
title_full DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
title_fullStr DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
title_full_unstemmed DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
title_short DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
title_sort danqi pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes b4
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933388/
https://www.ncbi.nlm.nih.gov/pubmed/24555740
http://dx.doi.org/10.1186/1472-6882-14-67
work_keys_str_mv AT wangyong danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT lichun danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT liuzhongyang danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT shitianjiao danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT wangqiyan danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT lidong danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT wuyan danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT hanjing danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT guoshuzhen danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT tangbinghua danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4
AT wangwei danqipillprotectsagainstheartfailurethroughthearachidonicacidmetabolismpathwaybyattenuatingdifferentcyclooxygenasesandleukotrienesb4